Clinical Trials Logo

Filter by:
NCT ID: NCT01605708 Terminated - Atopic Dermatitis Clinical Trials

Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis

Start date: June 2012
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to assess the clinical activity on refractory moderate-to-severe pruritus of a single intravenous (IV) dose of REGN846 in adult patients with moderate-to-severe atopic dermatitis (AD).

NCT ID: NCT01596829 Terminated - Clinical trials for Antibiotic-associated Diarrhoea

Effect of Probiotic Formula on Reducing the Risk for Antibiotic-associated Diarrhoea

Start date: December 2012
Phase: Phase 2/Phase 3
Study type: Interventional

Antibiotic treatment disturbs the balance of the intestinal microbiota and predisposes to antibiotic associated diarrhea. Previous studies have shown that the risk of developing diarrhea during a course of antibiotics may be reduced by simultaneous consumption of probiotics. The aim of the present study is to assess the effect of a probiotic formula containing four strains on reducing the risk of antibiotic associated diarrhea.

NCT ID: NCT01584752 Terminated - Surgery Clinical Trials

Gore-BioA Fistula Plug to Treat Transsphincteric Fistulas

Start date: November 2011
Phase:
Study type: Observational [Patient Registry]

This is a prospective clinical study on the efficacy of Gore-BioA fistula plug in high transsphincteric fistulas. Follow-up time is six months

NCT ID: NCT01544842 Terminated - Oral Lichen Planus Clinical Trials

Tacrolimus Ointment in Oral Lichen Planus

Start date: August 2004
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the effectiveness of topical tacrolimus, triamcinolone and placebo in alleviating signs and symptoms of oral lichen planus (OLP).

NCT ID: NCT01523600 Terminated - Falls Clinical Trials

Whole Body Vibration Training Among Older People Using Sheltered Housing

VAREX
Start date: October 2011
Phase: Phase 4
Study type: Interventional

The purpose of this randomised (double-blind) controlled exercise intervention trial is to determine whether the whole body vibration (WBV) training can effectively improve physical functioning of older people living in or regularly using services of sheltered housing, reduce their fear of falling, and prevent falling. The study comprises a 10-week training period and a 10-month follow-up period.

NCT ID: NCT01500785 Terminated - Myocardial Stunning Clinical Trials

Intracoronary Administration of Levosimendan in Cardiac Surgery Patients

Start date: June 15, 2018
Phase: Phase 4
Study type: Interventional

Incomplete recovery from ischemia causes stunned myocardium. Ischemia may be due to coronary artery disease or aortic cross-clamping during surgery. Stunning leads to myocardial dysfunction. It has been suggested that the mechanism responsible for the contractile depression in stunned myocardium is a decreased sensitivity of the myofibrils to calcium. Levosimendan is a calcium sensitizer, which has been shown to improve the function of stunned myocardium without obvious impairment of diastolic function. Systemic vasodilation and need of vasoconstrictive medication is usually apparent after administration of levosimendan. Colucci et al have demonstrated that with intracoronary administration of milrinone, another inodilator, systemic vasodilation could be excluded. If this is true with levosimendan, it may be possible to improve left ventricular hypo/dyskinesia without afterload reduction by adding levosimendan into cardioplegia solution. The investigators hypotize that levosimendan, delivered together with cardioplegia, can improve LV dysfunction after opening of aortic cross-clamp in patients undergoing aortic valve and coronary artery bypass operation. Our primary endpoint is a change in cardiac output 15 min after separation from cardiopulmonary bypass compared to the baseline. Secondary endpoints are a change in LV ejection fraction from baseline to 5 min after sternal closure and cTnT/CK-MB on the first postoperative morning.

NCT ID: NCT01499667 Terminated - Clinical trials for Relapsing Remitting Multiple Sclerosis (RRMS)

Disease Control and Safety in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) Switching From Natalizumab to Fingolimod

TOFIINGO
Start date: September 2011
Phase: Phase 3
Study type: Interventional

This study evaluated disease control during different lengths of treatment transition from natalizumab to fingolimod.

NCT ID: NCT01475929 Terminated - Clinical trials for Irritable Bowel Syndrome

Effect of Probiotic Supplement on Bowel Function

IBS2
Start date: June 2011
Phase: Phase 2
Study type: Interventional

The purpose of this study is to analyse the effect of probiotic supplement on symptoms of irritable bowel syndrome.

NCT ID: NCT01473446 Terminated - Clinical trials for Postoperative Complications

Traditional Versus Goal Directed Perioperative Fluid Therapy in High Risk Patients

Start date: January 2012
Phase: N/A
Study type: Interventional

Is goal directed fluid therapy reducing postoperative complications in comparison to traditional fluid therapy for gastro surgical ASA III/IV patients? The investigators compare two groups of patients: one group receives goal directed fluid therapy guided by LiDCOrapid stroke volume variation (SVV), the other gets the "traditional" fluids, ie the current regime.

NCT ID: NCT01436175 Terminated - Clinical trials for Major Depressive Disorder

SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study

Start date: February 27, 2012
Phase: Phase 3
Study type: Interventional

This study is an optional continuation of previous short-term adult major depressive disorder (MDD) augmentation studies. Patients may only take part in this long-term, open-label research study if they completed a previous double-blind MDD augmentation study using SPD489.